Temple Therapeutics Holdings Ltd — Form D
Temple Therapeutics Holdings Ltd of GELEEN, P7, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-09. The offering totals $1.0M, of which $300K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-12-09
- Form: D
- Accession: 0001213900-21-064369
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $300K
- Remaining: $700K
- Minimum investment: $100K
- Investors: 3
- Date of first sale: 2021-10-20
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-424341
Issuer
- Name: Temple Therapeutics Holdings Ltd
- CIK: 0001896459
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2020
- Address: URMONDERBAAN 22, GATE 2, GELEEN, P7, 6167 RD
- Phone: 3062615189
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Sanj Singh | Director | Saskatoon, A9 |
| Sanj Singh | Executive Officer | Saskatoon, A9 |
Other filings by this issuer (6)
More